Search Results 21-30 of 18989 for alzheimers
The Genetics of Alzheimer's Disease and Endophenotypes Lab under Dr. Ertekin-Taner studies underlying genetic risk and protective factors involved in AD.
An experimental drug for Alzheimer's disease shows promise to slow the progression of the diseas. A Mayo Clinic Neurologist gives perspective.
— Mayo Clinic researchers have proposed a new model for mapping the symptoms of Alzheimer's disease to brain anatomy. This model was developed by applying ...
Alzheimer's disease is the most common cause of dementia, which is a term used to describe a group of symptoms that affect memory, thinking and social abilities ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
In Alzheimer's disease, the brain cells degenerate and die, causing a steady decline in memory and mental function. At first, someone with Alzheimer's disease ...
Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to ...
A potential new Alzheimer's disease drug shows promise. Hear what a Mayo Clinic researcher and expert has to say about the treatment.
Mayo Clinic experts from many disciplines, including neurology, neuroscience, psychology and psychiatry, collaborate to provide you with the best Alzheimer's ...
The Mayo Clinic Alzheimer's Disease Research Center studies brain aging, Alzheimer's and related dementias. It provides support and resources to patients, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.